All Stories

  1. Hospitalization for Malignant Arrhythmias Following Initiation of Donepezil: A Retrospective Cohort Study
  2. Eligibility, Participation, and Matching Outcomes of International Pharmacy Graduates in Accredited Pharmacy Residency Programs in Canada: A Policy Scan and Cross-Sectional Analysis
  3. Administration of vaccines and injectable medications beyond 9 to 5: A cross-sectional analysis of over 1.2 million injection appointments scheduled at Canadian community pharmacies
  4. Survival After Opioid-Related Hospitalization and the Impact of Socioeconomic Status (SES) on Survival: A Population-Based Study
  5. Influenza vaccine effectiveness against laboratory-confirmed influenza infection among older patients hospitalized for cardiovascular events in Ontario: A test-negative design study
  6. Accessibility of Ontario pharmacies offering COVID-19 vaccination by rurality, community material deprivation, and ethnic concentration: a repeated cross-sectional geospatial analysis
  7. Healthcare costs and cost determinants of minor ailments: A population-based retrospective cohort study
  8. Fostering career-readiness in pharmacy students through work-integrated learning: Qualitative analysis of co-op supervisor and rotation preceptor feedback on student performance
  9. Income-Based Disparities in Opioid Prescription Dispensing Among Public Drug Plan Beneficiaries in Canada from 2010 to 2018: A Population-Based and Sex-Stratified Retrospective Study
  10. Validation of influenza vaccination status using health administrative databases by integrating pharmacy claims and medical billing databases in Ontario, Canada
  11. Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection Among Older Patients Hospitalized for Cardiovascular Events in Ontario: A Test-Negative Design Study
  12. Accessibility of Ontario pharmacies offering COVID-19 vaccination by rurality, community material deprivation, and ethnic concentration : A repeated cross-sectional geospatial analysis
  13. Association Between Opioid-Related Mortality and History of Surgical Procedure: A Population-Based Case-Control Study
  14. Health utilities in adults with hemophilia A: A retrospective cohort study
  15. Association between Pharmacists’ Country of Qualifying Education and Practising in a Hospital Setting: A Cross-Sectional Ontario Study
  16. Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom
  17. Herpes zoster and human papillomavirus vaccination opportunities identified using electronic prompts at the time of scheduling influenza or COVID-19 vaccines
  18. Évolution et déterminants de la vaccination contre la grippe saisonnière après une maladie cardiovasculaire au Canada : étude transversale pancanadienne répétée
  19. The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: a repeated, pan-Canadian, cross-sectional study
  20. Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario
  21. Stepping up to the Canadian opioid crisis: a longitudinal analysis of the correlation between socioeconomic status and population rates of opioid-related mortality, hospitalization and emergency department visits (2000–2017)
  22. Remédier à la crise des opioïdes au Canada : une analyse longitudinale de la corrélation entre le statut socioéconomique et les taux de décès, d’hospitalisations et de visites à l’urgence liés aux opioïdes dans la population (2000-2017)
  23. Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus
  24. The association between the rate of potentially pharmacist-manageable emergency department visits and community income level and primary care provider availability: A spatial analysis
  25. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs
  26. National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study
  27. Sodium-glucose cotransporter-2 inhibitors and urinary tract infections: A propensity score matched population-based cohort study.
  28. Trends and Determinants of Self-Reported Aspirin Use among Patients with Diabetes Stratified by the Presence and Risk of Cardiovascular Diseases - Repeated Pan-Canadian Cross-Sectional Study
  29. Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
  30. National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study
  31. Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis
  32. The Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus
  33. Development of comparable algorithms to measure primary care indicators using administrative health data across three Canadian provinces
  34. Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias – A narrative review
  35. Estimates of population‐based incidence of malignant arrhythmias associated with medication use—a narrative review
  36. The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study
  37. Achieving cross provincial comparisons of osteoporosis screening performance from administrative health data.
  38. Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada
  39. The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with expanded scope of practice
  40. 128 - Trend and Determinants of Cholesterol-Lowering Medication Use Among Patients With Diabetes Mellitus in Canada: A Repeated Cross-Sectional Study
  41. Pharmacy patron perspectives of community pharmacist administered influenza vaccinations
  42. Capsule Commentary on Goto et al.’s Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD
  43. Pharmacists as immunizers, their pharmacies and immunization services: A survey of Ontario community pharmacists
  44. Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada
  45. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines
  46. Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study
  47. Managing medications during Ramadan fasting
  48. Protecting our patients by protecting ourselves
  49. Multiple-domain Versus Single-domain Measurements of Socioeconomic Status (SES) for Predicting Nonadherence to Statin Medications
  50. Abstract 19486: Does the Association Between Adherence to Statin Medications and Mortality Depend on the Measurement Approach? A Retrospective Cohort Study
  51. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis
  52. Trends in Prevalence, Incidence and Pharmacologic Management of Diabetes Mellitus Among Seniors Newly Admitted to Long-Term Care Facilities in Saskatchewan between 2003 and 2011
  53. Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis
  54. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis
  55. Use and Misuse of Ezetimibe: Analysis of Use and Cost in Saskatchewan, a Canadian Jurisdiction With Broad Access
  56. Neighbourhood Income and Cardiac Rehabilitation Access as Determinants of Nonattendance and Noncompletion
  57. Pharmacologic Management of Diabetes among Seniors Newly Admitted to Long-term Care Facilities in Saskatchewan
  58. Incidence and Prevalence of Diabetes in Residents of Saskatchewan Long-Term Care Facilities between 2003 and 2011
  59. Pharmacist Intervention in Cardiac Rehabilitation